Over the next 14 years, Lisa and Steve were always my go-to experts on issues pertaining not only to drug advertising, efficacy, safety and screening, but also the growing phenomenon of overdiagnosis and overtreatment in medicine. I was familiar with the duo’s earlier work exposing the inadequacies inherent in many press releases lauding research findings and intrigued by their concept of having clear and understandable efficacy data in drug ads. That first call led to many, many more, and ultimately a number of important collaborations between the pair and Consumer Reports, beginning with Consumer Reports' “Best Buy Drugs” in 2004. They argued that a “ Drug Facts Box” was needed to accurately describe the benefits - and risks - of prescription drugs. I first had the honor and good fortune of connecting with Lisa and her partner Steve Woloshin in the early 2000s, not long after they had jointly published a Health Affairs article on the impact that direct-to-consumer prescription drug ads can have on the increased use of newly approved medications. Lisa is survived by her husband and two beautiful children. in cognitive developmental psychology from the University of Maryland.Late last month, we lost one of evidence-based medicine’s greatest thinkers and communicators of the last two decades when Lisa Schwartz passed away at the too-young age of 55. ![]() She presents at professional conferences including those of the Association of Change Management Professionals, the American Association for Public Opinion Research, and the American Psychological Association, and her work has been recognized for exceptional achievement by the secretary of the U.S. In addition, Schwartz has been published in peer-reviewed journals such as Monthly Labor Review and Educational Gerontology. She has also served on the National Academies’ Standing Committee on Integrating New Behavioral Health Measures into the Substance Abuse and Mental Health Services Administration’s data collection programs. ![]() A leading expert in employment and health survey research, she has designed and managed qualitative and quantitative studies of vulnerable populations. Schwartz brings more than 25 years of research and management experience to her role, directing efforts in business development, quality assurance, client relations, and innovative business practices. Over time, she has integrated business process and change management capabilities into the organization, introduced client experience management by designing and implementing “Voice of the Client” data collection and feedback loops, and developed a portfolio management approach to innovation. ![]() She plays a significant role in strategy execution and often leads critical strategic objectives, including the transforming of Mathematica’s culture from a product-centered to a client-centered one, and implementing an innovation framework to accelerate growth. Schwartz drives operational excellence by overseeing day-to-day business performance, establishing and maintaining alignment across all business leaders, and tracking, monitoring, analyzing, and interpreting key performance indicators. As chief operating officer, Lisa Schwartz works with the chief executive officer and other members of the senior executive team to pinpoint changes in Mathematica’s business context and determine how the organization will adapt to stay strong and competitive.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |